These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2232233)

  • 1. [Studies on the pathogenesis of hypercoagulability in patients with arterial thrombosis and malignancy].
    Uchiyama T; Andoh K; Tanaka H; Kobayashi N; Naruse T; Maekawa T
    Rinsho Byori; 1990 Jul; Suppl 86():125-33. PubMed ID: 2232233
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
    Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cellular mechanisms in the pathogenesis of thrombosis].
    Neri Serneri GG; Modesti PA
    Haematologica; 1991 Jun; 76 Suppl 3():261-70. PubMed ID: 1752521
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombosis and splenectomy. Preliminary note on the changes of various blood coagulation parameters 20 days after splenectomy. Experimental research].
    Di Vita G; Longo A; Di Gesù G; Avellone G; Mandalà V
    Minerva Chir; 1985 Apr; 40(8):533-6. PubMed ID: 4022410
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of blood coagulation in patients undergoing postoperative blood salvage and re-infusion of unwashed whole blood after total knee arthroplasty.
    Biagini D; Filippucci E; Agnelli G; Pagliaricci S
    Thromb Res; 2004; 113(3-4):211-5. PubMed ID: 15140585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathophysiology and treatment of thrombosis. (2) Blood coagulation disorders and their modulation system].
    Sakuragawa N
    Nihon Naika Gakkai Zasshi; 1987 Jan; 76(1):8-13. PubMed ID: 3553383
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome.
    Llach F
    Kidney Int; 1985 Sep; 28(3):429-39. PubMed ID: 3906225
    [No Abstract]   [Full Text] [Related]  

  • 9. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 11. [Functional significance of the clotting and anticlotting of the blood in the development of malignant neoplasms in the body].
    Kudriashov BA; Kalishevskaia TM; Kolomina SM
    Usp Fiziol Nauk; 1979; 10(2):3-23. PubMed ID: 157648
    [No Abstract]   [Full Text] [Related]  

  • 12. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.
    Langer F; Spath B; Haubold K; Holstein K; Marx G; Wierecky J; Brümmendorf TH; Dierlamm J; Bokemeyer C; Eifrig B
    Ann Hematol; 2008 Jun; 87(6):451-7. PubMed ID: 18292996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilia and complex acquired deficiencies of antithrombin, protein C, and protein S.
    Humphries JE
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):8-16; discussion 17-8. PubMed ID: 8821205
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrinogen, D-dimer and thrombin-antithrombin complexes in a random population sample: relationships with other cardiovascular risk factors.
    Giansante C; Fiotti N; Cattin L; Da Col PG; Calabrese S
    Thromb Haemost; 1994 May; 71(5):581-6. PubMed ID: 8091384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abnormality of blood coagulation before onset of DIC--risk factors for DIC].
    Wada H; Takagi M; Suzuki H; Deguchi K; Shirakawa S
    Rinsho Byori; 1990 Jul; Suppl 86():134-41. PubMed ID: 2232234
    [No Abstract]   [Full Text] [Related]  

  • 16. Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease--a preliminary study.
    Iversen LH; Okholm M; Thorlacius-Ussing O
    Thromb Haemost; 1996 Oct; 76(4):523-8. PubMed ID: 8902990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and antigenic antithrombin III values in plasma and serum from 115 regular blood donors and antithrombin III in prediction of postoperative thrombosis.
    Nilsen DW; Jeremic M; Weisert OK; Fønstelien E; Godal HC
    Thromb Haemost; 1983 Aug; 50(2):530-3. PubMed ID: 6415845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood coagulation factors and glycosaminoglycans].
    Sakuragawa N; Takahashi K; Sato S; Niwa M; Yamagishi R; Kazama Y
    Rinsho Byori; 1987 Sep; Spec No 73():134-41. PubMed ID: 3437528
    [No Abstract]   [Full Text] [Related]  

  • 19. The John Charnley Award. Thrombogenesis during total hip arthroplasty.
    Sharrock NE; Go G; Harpel PC; Ranawat CS; Sculco TP; Salvati EA
    Clin Orthop Relat Res; 1995 Oct; (319):16-27. PubMed ID: 7554626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postirradiation changes of plasma coagulation factors and inhibitors of coagulation.
    Klír P; Hlousková D; Pospísil J; Kase F
    Acta Univ Carol Med Monogr; 1987; 119():68-83. PubMed ID: 3324733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.